1.
To diagnose primary heart neoplasms with UCG
超声心动图对原发性心脏肿瘤的诊断
2.
Epidemiological features,clinical diagnosis and treatment of cardiac tumors
心脏肿瘤流行病学特点及其临床诊治
3.
The neoplasm with the greatest propensity to metastasize to heart is melanoma.
最易转移到心脏的肿瘤是黑色素瘤。
4.
Clinical Observation of Heart Injury after Radiotherapy in Treatment of Thoracic Malignancies;
胸部肿瘤放射治疗心脏损伤的临床观察
5.
Analysis of Heart Situation of 800 Cases of advanced Malignant Tumors
中晚期恶性肿瘤800例患者心脏情况分析
6.
Preliminary Study of Proton Magnetic Spectroscopy in Hepatic Malignant Tumor and Heart Ex Vivo;
肝脏恶性肿瘤、离体心脏氢质子磁共振波谱的初步研究
7.
HEPATIC BENIGN TUMOR AND TUMOR-LIKE LESIONS IN THE CHILDREN
小儿肝脏巨大良性肿瘤及肿瘤样病变
8.
Clinical Study of Myocardial Integrated Backscatter Parameters in Assessment of Cardiotoxity of Patients Treated with Anthracycline;
心肌背向散射积分参数评价蒽环类抗肿瘤药心脏毒性的临床研究
9.
Progression of echocardiography in assessment of cardiotoxicity induced by anticancer agents
超声心动图在抗肿瘤药物心脏毒性评价领域的进展
10.
Pancreatic cancer:Malignant tumour of the pancreas.
胰脏癌: 胰脏内的恶性肿瘤。
11.
The causes for hemoptysis include infection, cardiovascular disease, cancer, and vasculitis.
引起咳血的原因，包括有感染，心脏血管疾病，肿瘤，以及血管炎等。
12.
Mri reveals no tumors or cancers, no heart defects of any kind.
核磁共振显示没有肿瘤和癌症 没有任何类型的心脏疾病
13.
Contraindication: Vertebra tuberculosis osteoma, osteoporosis, Heart disease, Heavy diabetes, Pregnant women.
脊椎结核肿瘤、骨质疏松、严重心脏病、严重糖尿病、孕妇等。
14.
Clinical Study of Cardiac Function in Malignant Patients Treated with Anthracycline Using Tissue Doppler Imaging;
组织多普勒检测蒽环类药物对肿瘤患者心脏功能的影响
15.
Effects of Extracorporeal Whole Body Hyperthermia on Cardiac Function in Advanced Malignant Tumors
体外转流全身高热对晚期肿瘤患者心脏功能的影响
16.
A clinical research on Tei index in assessment of Myocardial Toxicity in cancer patients treated with anthracyclines
蒽环类药物对肿瘤患者心脏Tei指数影响的临床研究
17.
HEMANGIOSARCOMA - Malignant tumor that arises from the blood vessels of the liver.
血管肉瘤——发生于肝脏血管的恶性肿瘤。
18.
A benign tumor, most often found in the heart, that is composed of connective tissue embedded in mucus.
粘液瘤一种良性肿瘤,最常见于心脏,它由黏液里的胶状结缔组织构成